Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaramanakos, P. N.en
dc.contributor.authorPappas, P.en
dc.contributor.authorStephanou, P.en
dc.contributor.authorMarselos, M.en
dc.rightsDefault Licence-
dc.subjectAlcohol Dehydrogenase/metabolismen
dc.subjectAldehyde Dehydrogenase/metabolismen
dc.subjectBrain/*drug effects/metabolismen
dc.subjectDisulfiram/administration & dosage/*pharmacologyen
dc.subjectDose-Response Relationship, Drugen
dc.subjectEnzyme Inhibitors/administration & dosage/*pharmacologyen
dc.subjectInjections, Intraperitonealen
dc.subjectLiver/*drug effects/enzymologyen
dc.subjectRats, Wistaren
dc.titleDifferentiation of disulfiram effects on central catecholamines and hepatic ethanol metabolismen
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.abstractDisulfiram is used in the treatment of chronic alcoholism, because of the unpleasant symptoms it provokes after ethanol intake. The underlying mechanism is believed to be the accumulation of acetaldehyde in the blood, due to inhibition of the liver aldehyde dehydrogenases. In addition, it is known that disulfiram also has some neurotoxic properties. The aim of our study was to investigate the relationship between the pharmacological and neurotoxicological properties of disulfiram with respect to the doses applied. Increasing doses of disulfiram (25, 50, 75, 100 and 150 mg/kg) were administered intraperitoneally to Wistar rats and the hepatic enzyme activities of alcohol and aldehyde dehydrogenases were measured. Also, in two brain subregions (midbrain and hypothalamus) the levels of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid were determined. The higher dose of disulfiram (150 mg/kg) produced lethal effects in all treated animals. Aldehyde dehydrogenase activities were inhibited by disulfiram in a dose-dependent way, while alcohol dehydrogenase was not affected at all. Concerning the levels of brain biogenic amines, disulfiram produced a significant reduction in noradrenaline and an increase in dopamine levels in both structures of the brain, in a dose-dependent way. However, the lowest dose applied (25 mg/kg) had no effects on brain catecholamines. It is known that high doses of disulfiram may cause severe encephalopathy and peripheral neuropathy in humans, which could be attributed to the impairment of the metabolism of brain biogenic amines, due to inhibition of dopamine-beta-hydroxylase. Our experimental data show that disulfiram affects the level of brain biogenic amines at dose levels higher than those inhibiting the activity of aldehyde dehydrogenase. Therefore, in clinical practice 'disulfiram reaction' could still be achieved with a low dosage regimen not producing neurotoxicityen
heal.journalNamePharmacol Toxicolen
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Karamanakos-2001-Differentiation of d.pdf113.06 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons